Drug design is fundamentally a data science problem. Naturally, data science starts with the data, with a key challenge ...
Drug discovery is slow and expensive due to limited, low-quality, and poorly reproducible data for predicting how compounds will perform.
It generates high-quality biological datasets at scale and applies machine learning to design and prioritize drug candidates.
Pharmaceutical and biotechnology companies and drug discovery R&D teams.





